Skip to main content

"*" indicates required fields

Step 1 of 4

Join over 20,000 people who have chosen Enterra® Therapy – the first and only implantable device designed to help relieve nausea and vomiting from gastroparesis. See if you’re a candidate.

Have you been diagnosed by your doctor with gastroparesis caused by diabetes or an unknown origin?*
Image for choice number 1
Image for choice number 2

Question 1 of 3

For technical support, device-related questions, or help finding an Enterra provider, call Enterra Medical at 1-855-768-3772.

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

Regulatory statement

Enterra Ascent® has not been approved by the U.S. Food and Drug Administration (FDA). FDA has notified Enterra Medical that Enterra Ascent® and Enterra Entrust® may be distributed for implant under an FDA enforcement policy.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?